Ac 89
Actinium was discovered in 1899 by the German chemist Friedrich Oskar Giesel while he was investigating uranium minerals. He isolated it from pitchblende, a source of uranium ore, and named the element from the Greek word 'aktinos,' meaning 'ray,' due to its strong radioactivity. Initial research and interest in actinium were limited because of its scarcity and the challenges associated with handling radioactive materials. However, with advances in technology and methods for isolating radioactive isotopes, actinium gained attention. Its most stable isotope, Actinium-227, has found utility in various applications, particularly in radiation therapy and as a neutron source in nuclear reactors. The discovery of actinium marked a significant development in the field of radiochemistry, opening avenues for further research into other actinides and transuranic elements.
Actinium naturally occurs in trace amounts in uranium minerals, such as pitchblende and monazite, typically at concentrations of about 0.2 parts per million. It is formed through the decay of uranium and thorium isotopes. Actinium-227, the most commonly encountered isotope, is a decay product of uranium-235 and is found in uranium-rich ores. Due to its radioactivity, actinium is not accumulated in the Earth's crust in significant amounts. The natural abundance of actinium in the environment is extremely low, which contributes to its rarity and the complexity of isolating it for experimental and industrial uses. Additionally, actinium can be produced synthetically in nuclear reactors from the bombardment of thorium with neutrons.
Actinium does not have a known biological role and is highly radioactive, making it toxic to living organisms. Its radioactivity poses a significant health risk, particularly if ingested or inhaled. Most studies concerning actinium focus on its use in medical applications rather than any physiological importance. Because of its ability to emit alpha particles, actinium-227 is used in radiotherapy for treating certain types of cancer. The potential effects on human health underscore the need for careful handling and strict regulatory measures related to its use in medical and industrial settings.
Actinium is a silvery-white metal that exhibits a high degree of radioactivity. It has a melting point of 1050 degrees Celsius and a boiling point of around 1500 degrees Celsius. The metal is relatively soft, malleable and reacts vigorously with oxygen to form a coating of actinium oxide. Chemically, actinium is classified as an actinide and displays properties similar to those of other heavy metals. It readily forms +3 oxidation state compounds, although it can also exhibit +4 and +2 states in some of its compounds. Due to its radioactivity, handling actinium requires specialized equipment and precautions to mitigate exposure to radiation.
Actinium is primarily used in radiation therapy to treat cancer, specifically through its decay products that emit high-energy particles. One of its prominent isotopes, actinium-227, serves as a source of alpha particles for targeted alpha therapy (TAT). This technique involves attaching actinium to molecules that can target specific cancer cells, potentially reducing the damage to surrounding healthy tissue. Actinium is also utilized in scientific research as a neutron source in various experimental methods. However, its uses are mostly confined to specialized fields due to its hazardous nature and limited availability.